Since the company registration seventy events have happened. The last three records are Appointment of Dr Max Bylesjo as a director on 16 February 2017; Accounts for a small company made up to 30 April 2016; Annual return made up to 15 April 2016 with full list of shareholders Statement of capital on 2016-04-18 GBP 187.886 . The most likely internet sites of FIOS GENOMICS LIMITED are www.fiosgenomics.co.uk, and www.fios-genomics.co.uk. The predicted number of employees is 1 to 10. The company’s age is seventeen years and eight months. The distance to to Edinburgh Rail Station is 3.2 miles; to Slateford Rail Station is 4.5 miles; to Burntisland Rail Station is 10.3 miles; to Kinghorn Rail Station is 10.5 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Fios Genomics Limited is a Private Limited Company. The company registration number is SC341432. Fios Genomics Limited has been working since 15 April 2008. The present status of the company is Active. The registered address of Fios Genomics Limited is Nine Edinburgh Bioquarter Little France Road Edinburgh Eh16 4ux. . BYLESJO, Max, Dr is a Director of the company. GHAZAL, Peter, Professor is a Director of the company. JOHNSTON, Alan Mcdougall is a Director of the company. LYNAGH, Sarah, Dr is a Director of the company. RAMSAY, Martin William is a Director of the company. STRACHAN, Alistair, Dr is a Director of the company. Secretary BUCKIE, James William, Dr has been resigned. Secretary FREEMAN, Thomas Charles, Professor has been resigned. Secretary MBM SECRETARIAL SERVICES LIMITED has been resigned. Director BUCKIE, James William, Dr has been resigned. Director ENRIGHT, Anton James, Dr has been resigned. Director FORSTER, Thorsten has been resigned. Director FREEMAN, Thomas Charles, Professor has been resigned. Director FREEMAN, Thomas Charles, Professor has been resigned. Director PRIMROSE, Sandy, Dr has been resigned. Director RUBIN, Gary Leslie, Dr has been resigned. Director MBM NOMINEES LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".